ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Roy S. Herbst Masahiro Tsuboi |
| Publication date | May 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |